Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A L-Arginine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Arginine, including repackagers and relabelers. The FDA regulates L-Arginine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Arginine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Arginine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Arginine supplier is an individual or a company that provides L-Arginine active pharmaceutical ingredient (API) or L-Arginine finished formulations upon request. The L-Arginine suppliers may include L-Arginine API manufacturers, exporters, distributors and traders.
click here to find a list of L-Arginine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Arginine DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Arginine active pharmaceutical ingredient (API) in detail. Different forms of L-Arginine DMFs exist exist since differing nations have different regulations, such as L-Arginine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Arginine DMF submitted to regulatory agencies in the US is known as a USDMF. L-Arginine USDMF includes data on L-Arginine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Arginine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Arginine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The L-Arginine Drug Master File in Japan (L-Arginine JDMF) empowers L-Arginine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the L-Arginine JDMF during the approval evaluation for pharmaceutical products. At the time of L-Arginine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of L-Arginine suppliers with JDMF on PharmaCompass.
A L-Arginine CEP of the European Pharmacopoeia monograph is often referred to as a L-Arginine Certificate of Suitability (COS). The purpose of a L-Arginine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L-Arginine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L-Arginine to their clients by showing that a L-Arginine CEP has been issued for it. The manufacturer submits a L-Arginine CEP (COS) as part of the market authorization procedure, and it takes on the role of a L-Arginine CEP holder for the record. Additionally, the data presented in the L-Arginine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L-Arginine DMF.
A L-Arginine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L-Arginine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L-Arginine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Arginine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Arginine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Arginine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Arginine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Arginine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Arginine suppliers with NDC on PharmaCompass.
L-Arginine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Arginine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Arginine GMP manufacturer or L-Arginine GMP API supplier for your needs.
A L-Arginine CoA (Certificate of Analysis) is a formal document that attests to L-Arginine's compliance with L-Arginine specifications and serves as a tool for batch-level quality control.
L-Arginine CoA mostly includes findings from lab analyses of a specific batch. For each L-Arginine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Arginine may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Arginine EP), L-Arginine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Arginine USP).
LOOKING FOR A SUPPLIER?
